10h
GlobalData on MSNIllumina teases transcriptome profiling tech ahead of 2026 launchSet for release in 2026, the ‘first-of-its-kind’ technology aims to give researchers the ability to analyse more cells in a ...
Wolfe Research reiterated an Outperform rating and $150 price target on Illumina (ILMN) after Roche (RHHBY) presented scientific details about ...
Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers ...
which has been used at Illumina since 2007, builds upon earlier genome sequencing methods to greatly reduce the time taken to sequence DNA. When the 1,000 Genomes Project launched the following ...
The DNA Sequencing Industry has rapidly transformed into one of the most crucial areas of biotechnology. What was once a time ...
Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.
Roche, Illumina and Life Technologies ... The current library preparation methods for next-generation sequencing are time-consuming and prone to considerable sample loss. Even before library ...
Meanwhile, it doesn't seem coincidental that Illumina, which is the most significant genetic sequencing business in the world, has a large Chinese rival in biotech BGI Genomics. Ever feel like you ...
Work within a regulated sequencing workflow for developing ... in a research environment and use the full range of Illumina sequencing methods for a wide range of applications.
6d
ThePrint on MSNHow Chinese biotech firm BGI grew to rival US giant Illumina & enter US-China tariff warChina has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a global giant making genome sequencing equipment.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results